3-Carboxy-phthalimid | 776-22-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异吲哚及其衍生物
• 英文名称: 3-Carboxy-phthalimid
• 英文别名: 1,3-dioxo-2,3-dihydro-1H-isoindole-4-carboxylic acid；1,3-dioxoisoindole-4-carboxylic acid
• CAS: 776-22-7
• 化学式: C₉H₅NO₄
• mdl: MFCD20639778
• 分子量: 191.143
• InChiKey: BADJECWYJALBEL-UHFFFAOYSA-N

物化性质

• 密度：
  1.591±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  83.5
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-Carboxy-phthalimid 、 alkaline earth salt of/the/ methylsulfuric acid 生成 1,2,3-苯三甲酸
  参考文献：
  名称：

  Graebe; Leonhardt, Justus Liebigs Annalen der Chemie, 1896, vol. 290, p. 232

  摘要：

  DOI：
• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 氨 作用下， 生成 3-Carboxy-phthalimid
  参考文献：
  名称：

  Graebe; Leonhardt, Justus Liebigs Annalen der Chemie, 1896, vol. 290, p. 232

  摘要：

  DOI：

文献信息

• Azasugar derivatives, heparanase inhibitors, method for preparing same, compositions containing same, use thereof
  申请人：PETITOU Maurice

  公开号：US20070270354A1

  公开（公告）日：2007-11-22

  The invention concerns heparanase inhibiting compounds of general formula (I) wherein R represents a hydrogen atom, an hydroxyl radical, a —OSO 3 − radical, a —O—(C 1 -C 5 )alkyl radical or an —O— aralkyl radical; Z represents a COO − radical or a hydroxyl radical; X represents —OH or a saccharide unit of formula A, Y represents H, C 1 -C 5 alkyl or a saccharide unit of formula D; in free form or in the form of pharmaceutically acceptable salts formed with a base or an acid as well as in the form of solvates or hydrates. The derivatives of the invention are useful as medicines.

  该发明涉及通式（I）的肝素酶抑制化合物，其中R代表氢原子、羟基自由基、—OSO3−自由基、—O—（C1-C5）烷基自由基或—O—芳基烷基自由基；Z代表COO−自由基或羟基自由基；X代表—OH或通式A的糖单元；Y代表H、C1-C5烷基或通式D的糖单元；以游离形式或形成与碱或酸的药用可接受盐、溶剂化合物或水合物的形式存在。该发明的衍生物可用作药物。
• Derivatives of penicillanic acid
  申请人：Leo Pharmaceutical Products, Ltd. A/S

  公开号：US04229443A1

  公开（公告）日：1980-10-21

  The present invention relates to new substituted 6.beta.-amidinopenicillanic acids; pharmaceuticallyacceptable salts, easily hydrolyzable esters thereof and salts of such esters; to methods of producing the compounds; to intermediates in their preparation, to pharmaceutical compositions containing the compounds; to dosage units thereof; and to their use.

  本发明涉及新的取代6-beta-氨基青霉烷酸衍生物；其药用盐、易水解酯及其酯的盐；制备这些化合物的方法；其制备中间体；含有这些化合物的药物组合物；其剂量单位；以及它们的用途。
• [EN] PHTHALIMIDE CARBOXYLIC ACID DERIVATIVES<br/>[FR] DERIVES D'ACIDES CARBOXYLIQUES PHTALIMIDIQUES
  申请人：OXFORD GLYCOSCIENCES UK LTD

  公开号：WO2003074516A1

  公开（公告）日：2003-09-12

  The present invention relates to phthalimide carboxylic acid derivatives of formula (I), methods for their preparation, pharmaceutical compositions containing them and their use in medicine, specifically in the treatment of cancer. (I), wherein X is O or S; R1 is a phthalimide carboxylic acid group of formula (II). R is hydrogen, C1-C6 alkyl, aryl or C1-C3 alkylaryl and R2, R3 and R4 represent various substituents.

  本发明涉及公式（I）的邻苯二甲酰亚胺羧酸衍生物，其制备方法，含有它们的药物组合物以及它们在医学中的应用，具体用于癌症治疗。在公式（I）中，X为O或S；R1为公式（II）的邻苯二甲酰亚胺羧酸基团。R为氢、C1-C6烷基、芳基或C1-C3烷基芳基，R2、R3和R4代表各种取代基。
• Heparanase inhibitors and uses thereof
  申请人：Van Gelder M. Joel

  公开号：US20070185176A1

  公开（公告）日：2007-08-09

  The invention provides heparanase inhibitors suitable for treatment of diseases and disorders caused by or associated with heparanase catalytic activity such as cancer, inflammatory disorders and autoimmune diseases.

  该发明提供了适用于治疗由或与肝素酶催化活性相关的疾病和疾病的肝素酶抑制剂，例如癌症，炎症性疾病和自身免疫疾病。
• SYMMETRICAL TRIS-ARYL-AMIDE DERIVATIVES AND THEIR USE AS ANTI-HEPARANASE
  申请人：Leadiant Biosciences SA

  公开号：EP3381898A1

  公开（公告）日：2018-10-03

  The present invention relates to tris-aryl-amide derivatives having an anti-heparanase activity, in particular it relates to ureido/thioureido/ether tris-aryl-amide derivatives of formula The invention also relates to the use of such compounds as a medicament, in particular for the treatment of diseases and disorders associated with heparanase activity, and to pharmaceutical compositions comprising the same.

  本发明涉及具有抗肝素酶活性的三芳基酰胺衍生物，特别涉及公式的脲/硫脲/醚三芳基酰胺衍生物。本发明还涉及将这种化合物用作药物的用途，特别是用于治疗与肝素酶活性相关的疾病和障碍，并且涉及包含这些化合物的制药组合物。